Breaking News

Lonza, IBF Partner on Drug Development, Manufacture for Portfolio Cos

Offering aims to provide accelerated timelines for the development and manufacture of biologics and small molecules while mitigating risks.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Israel Biotech Fund (IBF), a venture fund investing in Israeli and Israeli-related biotech companies, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, entered an agreement whereby Lonza will add value to IBF through pre-investment due diligence support and offer IBF’s portfolio companies with tailored services for the development and manufacturing of biologics and small molecules. IBF will provide Lonza with access to IBF’s portfoli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters